H.C. Wainwright lowered the firm’s price target on Reviva Pharmaceuticals (RVPH) to $11 from $14 and keeps a Buy rating on the shares. Johnson ...

H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Disc Medicine (IRON – Research Report) today and set a price target of $118.00.

HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the“Company”), a leader in blockchain infrastructure and technology, has announced its ...

HC Wainwright reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report issued on Tuesday morning,Benzinga reports. HC Wainwright currently has a $42.00 ...

BigBear.ai Holdings Inc (BBAI) stock saw a modest uptick, ending the day at $4.41 which represents a slight increase of $0.49 or 12.50% from the prior close of $3.92. The stock opened at $3.94 and ...

If you want to stay updated on the latest options trades for SoundHound AI, Benzinga Pro gives you real-time options trades ...

SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or ...

Verve Therapeutics Inc (VERV) stock saw a modest uptick, ending the day at $6.57 which represents a slight increase of $0.43 or 7.00% from the prior close of $6.14. The stock opened at $6.25 and ...

Kapoor's target price reflects an upside potential for Summit of over 100%. Other Wall Street analysts are also bullish about ...

Palantir Technologies (NASDAQ:PLTR) has been described as the best pure-play stock in artificial intelligence. The market ...